Former FDA commissioner Scott Gottlieb (Photo by Mark Wilson/Getty Images)
January 27, 2022 01:39 PM ESTUpdated 02:17 PM
Pharma

Scott Got­tlieb crit­i­cizes CMS in feud over Aduhelm cov­er­age, calls out their lack of ex­per­tise

Paul Schloesser

Associate Editor

For­mer FDA com­mis­sion­er and cur­rent Pfiz­er board mem­ber Scott Got­tlieb went on the of­fen­sive against CMS this morn­ing — cit­ing the agency’s “flawed de­ci­sion mak­ing” …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times